Evaluation of S12363, a novel vinca alkaloid drug in the treatment of advanced malignant melanoma. A phase II study.

Stanley, A J

Evaluation of S12363, a novel vinca alkaloid drug in the treatment of advanced malignant melanoma. A phase II study. [electronic resource] - Anticancer research - 31-2 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article

0250-7005


Adult
Aged
Antineoplastic Agents, Phytogenic--therapeutic use
Dose-Response Relationship, Drug
Female
Humans
Male
Melanoma--drug therapy
Middle Aged
Vinca Alkaloids--therapeutic use